List of products by brand EXO|E (Croma Pharma)

EXO|E™ by Croma Pharma — Innovative Skin Care Based on Plant Exosomes

Unleash your skin's full potential with EXO|E™, the biotechnological skincare range from Croma Pharma, designed to revitalize, soothe, and restore skin before and after aesthetic procedures.

This is a professional treatment, intended for medical/aesthetic use only (not for unsupervised home use).

EXO|E™ is a 3-step revitalizing complex developed by Croma Pharma, based on plant-derived exosomes and other extracellular vesicles. This patented biomimetic technology supports the skin's natural self-healing mechanisms, particularly in the context of aesthetic treatments.

Technology and ingredients:

The EXO|E™ formulation is based on the culture of the Ustilago Cynodontis ferment and the activation of stem cells from Piper nigrum L. (black pepper) and Withania somnifera (ashwagandha) root. CF-α1 Complex: Thousands of plant-derived secretory factors, including peptides, liposomes, amino acids, proteins, and exosomes.

3-step treatment protocol:

• D|TOX — a pre-treatment serum for 7 days (morning and evening) to prepare the skin for the aesthetic procedure.
• EXO|E™ — an "in-office" serum to be administered in Clinical, soothing, and regenerating thanks to exosomes.
• RE|PAIR — post-treatment serum to be used for 7 days (morning and evening) to restore and calm the skin.

Treatment Protocol

• One kit (10 protocols) includes 10 EXO|E™ syringes (3 ml), 10 D|TOX vials (15 ml), and 10 RE|PAIR vials (15 ml) to cover the entire treatment period.
• Formulation: 100% natural, vegan, non-GMO, gluten-free, water-based.
• Vesicle Quantity: The EXO|E™ protocol includes approximately 30 billion extracellular vesicles according to Croma.
• Origin & Distribution: EXO|E™ is manufactured by Aesthetic Management Partners (USA) and distributed exclusively by Croma Pharma GmbH in Europe (European Union and Switzerland).

Key Benefits

• Optimal skin preparation before aesthetic procedures
• Soothing and regeneration during treatment
• Improved skin repair after the procedure
• Accelerated recovery and improved skin quality
• Biomimetic and natural approach, compatible with professional aesthetic protocols
• Why Choose EXO|E™

EXO|E™ by Croma Pharma stands out thanks to its plant exosome technology—a breakthrough in aesthetic medicine that combines the power of natural secretory factors with cutting-edge biotechnology. This protocol is designed to maximize the results of clinical treatments and minimize discomfort or recovery time, while respecting the skin's natural balance.

FAQ (6 questions) — EXO|E (Croma)

What is Croma Pharma's EXO|E™?

EXO|E™ is a professional skincare line designed to complement aesthetic procedures, using plant exosomes and other extracellular vesicles to stimulate skin regeneration.

How does the 3-step EXO|E™ protocol work?

The protocol includes:

• D|TOX: Pre-treatment serum applied for 7 days prior to the procedure.
• EXO|E™: Serum to be applied in the clinic on the day of the procedure. the procedure.
• RE|PAIR: Post-treatment serum for 7 days after the procedure to promote repair.

What are the key ingredients of EXO|E™?

The EXO|E™ complex is based on:

• A plant ferment (Ustilago Cynodontis)
• Stem cells from Piper nigrum L. (black pepper) and Withania somnifera (ashwagandha) root
• It contains thousands of plant-derived secretory factors (growth factors, peptides, liposomes, amino acids, proteins) and exosomes.

Is EXO|E™ compatible with all skin types?

Yes, according to Croma, EXO|E™ is formulated with 100% Natural, vegan, GMO-free, and gluten-free, making it very well tolerated. However, this is a professional treatment, reserved for medical/aesthetic use (not for unsupervised home use).

Does EXO|E™ accelerate recovery after a cosmetic procedure?

Yes: Thanks to exosomes and CF-α1 secretory factors, EXO|E™ supports the skin's natural repair processes, which can reduce recovery time and improve the quality of skin regeneration.

How many vesicles are in an EXO|E™ protocol?

Croma indicates that the EXO|E™ protocol includes approximately 30 billion extracellular vesicles (exosomes and others) to maximize